Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Among patients with OSA who had no prior CPAP use, only 4% of those who initiated tirzepatide went on to start CPAP therapy within six months, compared with 22% of those without GLP-1 exposure
Wang C, Li Q, Wang W, Guo L, Guo C, Sun Y, et al
Includes daily habit lessons, food tracking, a vibrant community, and interactive progress tools designed to strengthen long-term habits
Research on GLP-1 receptor agonists shows that these medications reduce activation in brain regions associated with food reward, including the insula, amygdala, and orbitofrontal cortex
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
7,8 South Carolina Medicaid added coverage of weight loss GLP-1s on November 1, 2024, and recently removed coverage effective January 1, 2026
US$ 27.05
US$ 28.21
US$ 20.27
US$ 27.08
US$ 25.63
US$ 23.12
US$ 27.09
US$ 20.80
US$ 28.04
US$ 23.65
US$ 25.50
US$ 26.94
US$ 29.07
US$ 22.74
US$ 22.18
